Search results
Merck KGaA's Q1 adjusted profit declines less than feared
Reuters· 12 hours ago, opens new tab on Wednesday reported better-than-expected adjusted earnings, helped by strong...
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Clinical Trials Arena via Yahoo Finance· 1 day agoUS pharmaceutical company Merck & Co Inc (MSD) has discontinued a Phase III trial investigating a...
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
FierceBiotech· 3 hours agoWhat a time to be launching a new biotech focused on inflammation and immunology. Uniquity Bio is...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 2 days agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
Why Merck & Co Inc (NYSE: MRK) Is A Stock Not To Be Discarded In 2024 – Marketing Sentinel
Marketing Sentinel· 2 days agoIn today’s recent session, 2.33 million shares of the Merck & Co Inc (NYSE:MRK) have been traded, and its beta is 0.42. Most recently the company’s share price was $128.25 ...
Merck KGaA Confirms Outlook After Drop in Sales, Earnings
Morningstar· 13 hours agoGermany's Merck KGaA confirmed and detailed its guidance for 2024 after it reported lower sales and earnings for the first quarter, hit by inventory reductions at its life-science ...
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga via Yahoo Finance· 2 days agoMonday, Merck & Co Inc (NYSE:MRK) announced the discontinuation of the vibostolimab and...
American Red Cross Receives Pledge from Merck to Support Health-Related Needs Caused by Record...
WKRN Nashville· 1 day agoThe American Red Cross announced today that it has received a generous pledge from Merck & Co., Inc., a leading global biopharmaceutical company, to provide support for health-related ...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 2 days agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters via AOL· 2 days agoThis is the latest setback for the experimental drug, vibostolimab, and the related promising new...